Critical care primary services are associated with reduced midazolam use in the intensive care unit

Table 5 Multivariate analysis on demographics and risk factors associated with the use of continuous midazolam infusion

Predictors	OR	95%CI (lower limit, upper limit)	P value
Age > 65 years	0.43	0.31, 0.59	< 0.0001
Teaching ICU	0.31	0.23, 0.42	< 0.0001
CCM primary	0.11	0.08, 0.16	< 0.0001
Charlson score > 5	0.94	0.69, 1.29	0.7151
SOFA score > 7	1.74	1.30, 2.33	0.0002
Acute respiratory failure	2.11	1.51, 2.94	< 0.0001
ARDS	6.95	3.82, 12.64	< 0.0001
Cardiogenic shock	3.01	1.95, 4.64	< 0.0001
Septic shock	0.80	0.51, 1.25	0.3324
Sepsis	1.22	0.79, 1.88	0.3714
Hypovolemic shock	1.05	0.52, 2.12	0.8912
Unspecified shock	1.51	1.00, 2.28	0.0504
Cardiac arrest	1.38	0.94, 2.02	0.1034
Pneumonia (bacterial)	1.56	1.14, 2.14	0.005
Viral pneumonia	7.80	2.11, 28.80	0.0021
COVID PNA	0.41	0.11, 1.49	0.1742
Seizure	1.77	0.92, 3.42	0.0895
Status epilepticus	13.17	6.56, 26.45	< 0.0001
Alcohol withdrawal	2.30	1.41, 3.74	0.0008

OR: Odds ratios; CI: Confidence interval; ICU: Intensive care unit; CCM: Critical care medicine; SOFA: Sequential Organ Failure Assessment; ARDS: Acute respiratory distress syndrome; COVID PNA: Coronavirus disease peptide nucleic acid.